Skip to main content
. 2022 Mar 10;14(6):1420. doi: 10.3390/cancers14061420

Figure 2.

Figure 2

Mechanism of resistance to polyADP-ribose polymerase (PARP) inhibitors. Several resistance mechanisms have been identified: reversion mutation, DNA polymerase θ (POLQ), loss of shieldin complex, stabilization of replication fork, increased drug efflux, overexpression of cyclin-dependent kinase 12 (CDK12) and WEE1.